Oral Cancer Diagnostic Market, Global Outlook and Forecast 2022-2028

April 2022 | 64 pages | ID: OCA877CF743DEN
Market Monitor Global

Abstracts

Oral Cancer Diagnostic is a doctor who discovers or diagnoses cancer through a series of tests on the mouth.

This report contains market size and forecasts of Oral Cancer Diagnostic in Global, including the following market information:

Global Oral Cancer Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Oral Cancer Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Computed Tomography (CT) Scan Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oral Cancer Diagnostic include GE Healthcare, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Siemens Healthineers, Hitachi Ltd, PeriRx, LLC, Canon Medical Systems Corporation , Vigilant Biosciences, Inc. and QIAGEN and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Cancer Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oral Cancer Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Oral Cancer Diagnostic Market Segment Percentages, by Type, 2021 (%)

• Computed Tomography (CT) Scan
• Magnetic Resonance Imaging (MRI)
• Positron Emission Tomography (PET)
• Ultrasonography
• Biopsy
• X-Ray
• Endoscopy
• Fluorescence Imaging
• Others

Global Oral Cancer Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Oral Cancer Diagnostic Market Segment Percentages, by Application, 2021 (%)

• Hospitals and Clinics
• Research and Academic Institutes
• Others

Global Oral Cancer Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Oral Cancer Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Oral Cancer Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Oral Cancer Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GE Healthcare
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Siemens Healthineers
• Hitachi Ltd
• PeriRx, LLC
• Canon Medical Systems Corporation
• Vigilant Biosciences, Inc.
• QIAGEN
• Koninklijke Philips NV

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oral Cancer Diagnostic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oral Cancer Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ORAL CANCER DIAGNOSTIC OVERALL MARKET SIZE

2.1 Global Oral Cancer Diagnostic Market Size: 2021 VS 2028
2.2 Global Oral Cancer Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Oral Cancer Diagnostic Players in Global Market
3.2 Top Global Oral Cancer Diagnostic Companies Ranked by Revenue
3.3 Global Oral Cancer Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Oral Cancer Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Oral Cancer Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oral Cancer Diagnostic Players in Global Market
  3.6.1 List of Global Tier 1 Oral Cancer Diagnostic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Oral Cancer Diagnostic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Oral Cancer Diagnostic Market Size Markets, 2021 & 2028
  4.1.2 Computed Tomography (CT) Scan
  4.1.3 Magnetic Resonance Imaging (MRI)
  4.1.4 Positron Emission Tomography (PET)
  4.1.5 Ultrasonography
  4.1.6 Biopsy
  4.1.7 X-Ray
  4.1.8 Endoscopy
  4.1.9 Fluorescence Imaging
  4.1.10 Others
4.2 By Type - Global Oral Cancer Diagnostic Revenue & Forecasts
  4.2.1 By Type - Global Oral Cancer Diagnostic Revenue, 2017-2022
  4.2.2 By Type - Global Oral Cancer Diagnostic Revenue, 2023-2028
  4.2.3 By Type - Global Oral Cancer Diagnostic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oral Cancer Diagnostic Market Size, 2021 & 2028
  5.1.2 Hospitals and Clinics
  5.1.3 Research and Academic Institutes
  5.1.4 Others
5.2 By Application - Global Oral Cancer Diagnostic Revenue & Forecasts
  5.2.1 By Application - Global Oral Cancer Diagnostic Revenue, 2017-2022
  5.2.2 By Application - Global Oral Cancer Diagnostic Revenue, 2023-2028
  5.2.3 By Application - Global Oral Cancer Diagnostic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Oral Cancer Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Oral Cancer Diagnostic Revenue & Forecasts
  6.2.1 By Region - Global Oral Cancer Diagnostic Revenue, 2017-2022
  6.2.2 By Region - Global Oral Cancer Diagnostic Revenue, 2023-2028
  6.2.3 By Region - Global Oral Cancer Diagnostic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Oral Cancer Diagnostic Revenue, 2017-2028
  6.3.2 US Oral Cancer Diagnostic Market Size, 2017-2028
  6.3.3 Canada Oral Cancer Diagnostic Market Size, 2017-2028
  6.3.4 Mexico Oral Cancer Diagnostic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Oral Cancer Diagnostic Revenue, 2017-2028
  6.4.2 Germany Oral Cancer Diagnostic Market Size, 2017-2028
  6.4.3 France Oral Cancer Diagnostic Market Size, 2017-2028
  6.4.4 U.K. Oral Cancer Diagnostic Market Size, 2017-2028
  6.4.5 Italy Oral Cancer Diagnostic Market Size, 2017-2028
  6.4.6 Russia Oral Cancer Diagnostic Market Size, 2017-2028
  6.4.7 Nordic Countries Oral Cancer Diagnostic Market Size, 2017-2028
  6.4.8 Benelux Oral Cancer Diagnostic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Oral Cancer Diagnostic Revenue, 2017-2028
  6.5.2 China Oral Cancer Diagnostic Market Size, 2017-2028
  6.5.3 Japan Oral Cancer Diagnostic Market Size, 2017-2028
  6.5.4 South Korea Oral Cancer Diagnostic Market Size, 2017-2028
  6.5.5 Southeast Asia Oral Cancer Diagnostic Market Size, 2017-2028
  6.5.6 India Oral Cancer Diagnostic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Oral Cancer Diagnostic Revenue, 2017-2028
  6.6.2 Brazil Oral Cancer Diagnostic Market Size, 2017-2028
  6.6.3 Argentina Oral Cancer Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Oral Cancer Diagnostic Revenue, 2017-2028
  6.7.2 Turkey Oral Cancer Diagnostic Market Size, 2017-2028
  6.7.3 Israel Oral Cancer Diagnostic Market Size, 2017-2028
  6.7.4 Saudi Arabia Oral Cancer Diagnostic Market Size, 2017-2028
  6.7.5 UAE Oral Cancer Diagnostic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GE Healthcare
  7.1.1 GE Healthcare Corporate Summary
  7.1.2 GE Healthcare Business Overview
  7.1.3 GE Healthcare Oral Cancer Diagnostic Major Product Offerings
  7.1.4 GE Healthcare Oral Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.1.5 GE Healthcare Key News
7.2 F. Hoffmann-La Roche Ltd
  7.2.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.2.2 F. Hoffmann-La Roche Ltd Business Overview
  7.2.3 F. Hoffmann-La Roche Ltd Oral Cancer Diagnostic Major Product Offerings
  7.2.4 F. Hoffmann-La Roche Ltd Oral Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.2.5 F. Hoffmann-La Roche Ltd Key News
7.3 Thermo Fisher Scientific Inc.
  7.3.1 Thermo Fisher Scientific Inc. Corporate Summary
  7.3.2 Thermo Fisher Scientific Inc. Business Overview
  7.3.3 Thermo Fisher Scientific Inc. Oral Cancer Diagnostic Major Product Offerings
  7.3.4 Thermo Fisher Scientific Inc. Oral Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.3.5 Thermo Fisher Scientific Inc. Key News
7.4 Siemens Healthineers
  7.4.1 Siemens Healthineers Corporate Summary
  7.4.2 Siemens Healthineers Business Overview
  7.4.3 Siemens Healthineers Oral Cancer Diagnostic Major Product Offerings
  7.4.4 Siemens Healthineers Oral Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.4.5 Siemens Healthineers Key News
7.5 Hitachi Ltd
  7.5.1 Hitachi Ltd Corporate Summary
  7.5.2 Hitachi Ltd Business Overview
  7.5.3 Hitachi Ltd Oral Cancer Diagnostic Major Product Offerings
  7.5.4 Hitachi Ltd Oral Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.5.5 Hitachi Ltd Key News
7.6 PeriRx, LLC
  7.6.1 PeriRx, LLC Corporate Summary
  7.6.2 PeriRx, LLC Business Overview
  7.6.3 PeriRx, LLC Oral Cancer Diagnostic Major Product Offerings
  7.6.4 PeriRx, LLC Oral Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.6.5 PeriRx, LLC Key News
7.7 Canon Medical Systems Corporation
  7.7.1 Canon Medical Systems Corporation Corporate Summary
  7.7.2 Canon Medical Systems Corporation Business Overview
  7.7.3 Canon Medical Systems Corporation Oral Cancer Diagnostic Major Product Offerings
  7.7.4 Canon Medical Systems Corporation Oral Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.7.5 Canon Medical Systems Corporation Key News
7.8 Vigilant Biosciences, Inc.
  7.8.1 Vigilant Biosciences, Inc. Corporate Summary
  7.8.2 Vigilant Biosciences, Inc. Business Overview
  7.8.3 Vigilant Biosciences, Inc. Oral Cancer Diagnostic Major Product Offerings
  7.8.4 Vigilant Biosciences, Inc. Oral Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.8.5 Vigilant Biosciences, Inc. Key News
7.9 QIAGEN
  7.9.1 QIAGEN Corporate Summary
  7.9.2 QIAGEN Business Overview
  7.9.3 QIAGEN Oral Cancer Diagnostic Major Product Offerings
  7.9.4 QIAGEN Oral Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.9.5 QIAGEN Key News
7.10 Koninklijke Philips NV
  7.10.1 Koninklijke Philips NV Corporate Summary
  7.10.2 Koninklijke Philips NV Business Overview
  7.10.3 Koninklijke Philips NV Oral Cancer Diagnostic Major Product Offerings
  7.10.4 Koninklijke Philips NV Oral Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.10.5 Koninklijke Philips NV Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Oral Cancer Diagnostic Market Opportunities & Trends in Global Market
Table 2. Oral Cancer Diagnostic Market Drivers in Global Market
Table 3. Oral Cancer Diagnostic Market Restraints in Global Market
Table 4. Key Players of Oral Cancer Diagnostic in Global Market
Table 5. Top Oral Cancer Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Oral Cancer Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Oral Cancer Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Oral Cancer Diagnostic Product Type
Table 9. List of Global Tier 1 Oral Cancer Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Cancer Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Oral Cancer Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Oral Cancer Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Oral Cancer Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Oral Cancer Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Oral Cancer Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Oral Cancer Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Oral Cancer Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Oral Cancer Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Oral Cancer Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Oral Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Oral Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Oral Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Oral Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Oral Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. GE Healthcare Corporate Summary
Table 31. GE Healthcare Oral Cancer Diagnostic Product Offerings
Table 32. GE Healthcare Oral Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche Ltd Corporate Summary
Table 34. F. Hoffmann-La Roche Ltd Oral Cancer Diagnostic Product Offerings
Table 35. F. Hoffmann-La Roche Ltd Oral Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Inc. Corporate Summary
Table 37. Thermo Fisher Scientific Inc. Oral Cancer Diagnostic Product Offerings
Table 38. Thermo Fisher Scientific Inc. Oral Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. Siemens Healthineers Corporate Summary
Table 40. Siemens Healthineers Oral Cancer Diagnostic Product Offerings
Table 41. Siemens Healthineers Oral Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Hitachi Ltd Corporate Summary
Table 43. Hitachi Ltd Oral Cancer Diagnostic Product Offerings
Table 44. Hitachi Ltd Oral Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. PeriRx, LLC Corporate Summary
Table 46. PeriRx, LLC Oral Cancer Diagnostic Product Offerings
Table 47. PeriRx, LLC Oral Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Canon Medical Systems Corporation  Corporate Summary
Table 49. Canon Medical Systems Corporation  Oral Cancer Diagnostic Product Offerings
Table 50. Canon Medical Systems Corporation  Oral Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. Vigilant Biosciences, Inc. Corporate Summary
Table 52. Vigilant Biosciences, Inc. Oral Cancer Diagnostic Product Offerings
Table 53. Vigilant Biosciences, Inc. Oral Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. QIAGEN Corporate Summary
Table 55. QIAGEN Oral Cancer Diagnostic Product Offerings
Table 56. QIAGEN Oral Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. Koninklijke Philips NV Corporate Summary
Table 58. Koninklijke Philips NV Oral Cancer Diagnostic Product Offerings
Table 59. Koninklijke Philips NV Oral Cancer Diagnostic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Oral Cancer Diagnostic Segment by Type in 2021
Figure 2. Oral Cancer Diagnostic Segment by Application in 2021
Figure 3. Global Oral Cancer Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Oral Cancer Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oral Cancer Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oral Cancer Diagnostic Revenue in 2021
Figure 8. By Type - Global Oral Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Oral Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Oral Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Oral Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Oral Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Oral Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Oral Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Oral Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Oral Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. GE Healthcare Oral Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche Ltd Oral Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Inc. Oral Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Siemens Healthineers Oral Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Hitachi Ltd Oral Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. PeriRx, LLC Oral Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Canon Medical Systems Corporation  Oral Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Vigilant Biosciences, Inc. Oral Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. QIAGEN Oral Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Koninklijke Philips NV Oral Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)